BRANFORD, Conn., May 29, 2007 /PRNewswire/ — 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain in Branford, Connecticut as a member of the Roche Diagnostics organization.
The 454 Life Sciences, now part of Roche Diagnostics, and researchers from the Baylor College of Medicine (BCM) in Houston, US will present James Watson, co-discoverer of the DNA double helix and developer of the human genome project with his personal genome DNA sequence data at on May 31
related articles
eyeon DNA -Dr. Jim Watson’s Genome Sequenced for 2 Million Dollars
BRANFORD, Conn., May 29, 2007 /PRNewswire/ — 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain in Branford, Connecticut as a member of the Roche Diagnostics organization.
The 454 Life Sciences, now part of Roche Diagnostics, and researchers from the Baylor College of Medicine (BCM) in Houston, US will present James Watson, co-discoverer of the DNA double helix and developer of the human genome project with his personal genome DNA sequence data at on May 31
related articles
eyeon DNA -Dr. Jim Watson’s Genome Sequenced for 2 Million Dollars
Geneengnews curagen closes 454life sciences transaction
Filed under: DNA network, DNA news, bioinformatics blog, genome sequencing